EX-3 4 dex3.htm JOINT FILING AGREEMENT Joint Filing Agreement

Exhibit 3

Joint Filing Agreement

This will confirm the agreement by and among all the undersigned that the Statement on Schedule 13D filed on or about this date and any further amendments thereto with respect to beneficial ownership by the undersigned of the shares of the common stock, no par value per share, of DepoMed, Inc, a California corporation, is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934.

The undersigned further agree that each party hereto is responsible for timely filing of such Statement on Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, provided that no party is responsible for the completeness and accuracy of the information concerning any other party, unless such party knows or has reason to believe that such information is inaccurate. The undersigned further agree that this agreement shall be included as an Exhibit to such joint filing.

This agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

MDS Capital Corp.

 

 

 

By: 

/s/ GREGORY GUBITZ



/s/ GRAYSANNE BEDELL

 

Date:



April 29, 2003

 

 

 


Name:

Gregory Gubitz

Graysanne Bedell

 

 

 

Title:

Sr. Vice-President

and Secretary

Vice-President—Legal 

 

 

 

 

MDS Life Sciences Technology Fund II NC Limited Partnership
By: MDS LSTF II (NCGP) Inc., its General Partner

 

 

 

By:

/s/ GREGORY GUBITZ



/s/ GRAYSANNE BEDELL

 

Date:



April 29, 2003

 

 

 


Name: 

Gregory Gubitz

 Graysanne Bedell

 

 

 

Title: 

Vice-President

and Director

 Secretary

 

 

 

 

MDS Life Sciences Technology Fund II Quebec

Limited Partnership
By: MDS LSTF II (QGP) Inc., its General Partner

 

 

 

 

By:

/s/ GREGORY GUBITZ



/s/ GRAYSANNE BEDELL

 

Date:



April 29, 2003

 

 

 


Name: 

Gregory Gubitz

 Graysanne Bedell

 

 

 

Title: 

Vice-President

 Secretary

 

 

 

 



 

Joint Filing Agreement

Schedule 13D

Page 2 of 3

 

SC Biotechnology Development Fund
By: SC (GP) Inc., its General Partner

 

 

 

By: /s/ EVE WILSON



/s/ WILLIAM WALMSLEY

 

Date:



 29 April 2003


 


Name: Eve Wilson

William Walmsley

 

 

 

Title: Director of Cardinal Investments Limited

Director of SC (GP) Inc.

 

 

 

 

MDS LSTF II (NCGP) Inc.

 

 

 

By: /s/ GREGORY GUBITZ



/s/ GRAYSANNE BEDELL

 

Date:



 April 29, 2003


 


Name: Gregory Gubitz

 Graysanne Bedell

 

 

 

Title: Vice-President and Director

 Secretary

 

 

 

 

MDS LSTF II (QGP) Inc.

 

 

 

By: /s/ GREGORY GUBITZ



/s/ GRAYSANNE BEDELL

 

Date:



 April 29, 2003


 

 


Name: Gregory Gubitz

 Graysanne Bedell

 

 

 

Title: Vice-President

 Secretary

 

 

 

 

MLII (NCGP) Inc.

 

 

 

By: /s/ GREGORY GUBITZ



/s/ GRAYSANNE BEDELL

 

Date:



 April 29, 2003


 

 


Name: Gregory Gubitz

  Graysanne Bedell

 

 

 

Title: Vice-President and Director

 Secretary

 

 

 

 

 

SC (GP) Inc.

 

 

 

By: /s/ EVE WILSON



/s/ WILLIAM WALMSLEY

 

Date:



 April 29, 2003


 

 


Name: Eve Wilson  

 William Walmsley

 

 

 

Title: Director of Cardinal Investments Limited 

 Director of SC (GP) Inc.

 

 

 



 

Joint Filing Agreement

Schedule 13D

Page 3 of 3

 

MDS Health Ventures Management Inc.

 

 

 

By: /s/ MICHAEL CALLAGHAN



/s/ RICHARD LOCKIE

 

Date:



 April 29, 2003


 

 


Name: Michael Callaghan  

 Richard Lockie

 

 

 

Title: Vice-President

 Vice-President

 

 

 

 

 

 

 

 /s/ MICHAEL CALLAGHAN



 

Date:



 April 29, 2003


 

 


Michael Callaghan